Hepatitis delta virus

[1]  M. Manns,et al.  Peginterferon plus adefovir versus either drug alone for hepatitis delta. , 2011, The New England journal of medicine.

[2]  M. Levrero,et al.  Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. , 2010, European journal of public health.

[3]  M. Buti,et al.  Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. , 2010, Journal of hepatology.

[4]  Hsei-Wei Wang,et al.  Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus. , 2010, The Journal of general virology.

[5]  M. Manns,et al.  Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics , 2010, Journal of Clinical Microbiology.

[6]  Johnm . Taylor,et al.  Origin of hepatitis delta virus. , 2010, Future microbiology.

[7]  M. Manns,et al.  Quantitative HBsAg and HDV‐RNA levels in chronic delta hepatitis , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[8]  B. McMahon,et al.  Hepatitis D outbreak among children in a hepatitis B hyper‐endemic settlement in Greenland , 2010, Journal of viral hepatitis.

[9]  Z. Abbas,et al.  Hepatitis D: Scenario in the Asia-Pacific region. , 2010, World journal of gastroenterology.

[10]  M. Desvarieux,et al.  Longitudinal evaluation of viral interactions in treated HIV‐hepatitis B co‐infected patients with additional hepatitis C and D virus , 2010, Journal of viral hepatitis.

[11]  Y. Ni,et al.  Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction , 2009, Journal of Virology.

[12]  H. Tillmann,et al.  Virological and clinical characteristics of delta hepatitis in Central Europe , 2009, Journal of viral hepatitis.

[13]  S. Nwokediuko,et al.  Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. , 2009, Nigerian journal of clinical practice.

[14]  Pei‐Jer Chen,et al.  Phosphorylation of Serine 177 of the Small Hepatitis Delta Antigen Regulates Viral Antigenomic RNA Replication by Interacting with the Processive RNA Polymerase II , 2009, Journal of Virology.

[15]  M. Lai,et al.  Modification of Small Hepatitis Delta Virus Antigen by SUMO Protein , 2009, Journal of Virology.

[16]  D. Hober,et al.  Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. , 2009, The Journal of general virology.

[17]  C. Chien,et al.  Clathrin-Mediated Post-Golgi Membrane Trafficking in the Morphogenesis of Hepatitis Delta Virus , 2009, Journal of Virology.

[18]  Z. Abbas,et al.  Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. , 2009, JPMA. The Journal of the Pakistan Medical Association.

[19]  C. Sureau,et al.  A Function Essential to Viral Entry Underlies the Hepatitis B Virus “a” Determinant , 2009, Journal of Virology.

[20]  S. Farhang,et al.  The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? , 2009, Tropical doctor.

[21]  Mulyanto,et al.  A nationwide molecular epidemiological study on hepatitis B virus in Indonesia: identification of two novel subgenotypes, B8 and C7 , 2009, Archives of Virology.

[22]  R. Diaz,et al.  Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. , 2009, The Journal of infectious diseases.

[23]  M. Kazanji,et al.  Prevalence and Molecular Diversity of Hepatitis B Virus and Hepatitis Delta Virus in Urban and Rural Populations in Northern Gabon in Central Africa , 2009, Journal of Clinical Microbiology.

[24]  M. Rizzetto.  Hepatitis D: thirty years after. , 2009, Journal of hepatology.

[25]  M. Colombo,et al.  A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. , 2009, Gastroenterology.

[26]  M. Pelchat,et al.  The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. , 2009, Virology.

[27]  S. Lo,et al.  The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin , 2009, Virology Journal.

[28]  M. Rizzetto,et al.  Ribavirin treatment for chronic hepatitis D: a pilot study. , 2008, Liver.

[29]  Y. Tsay,et al.  ERK1/2-Mediated Phosphorylation of Small Hepatitis Delta Antigen at Serine 177 Enhances Hepatitis Delta Virus Antigenomic RNA Replication , 2008, Journal of Virology.

[30]  C. Yurdaydın,et al.  Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon , 2008, Journal of viral hepatitis.

[31]  C. Yurdaydın,et al.  Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta‐analysis , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[32]  M. Hussain,et al.  The increasing prevalence of hepatitis delta virus (HDV) infection in South London , 2008, Journal of medical virology.

[33]  M. Sugiyama,et al.  Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan , 2008, Journal of medical virology.

[34]  C. Toro,et al.  Does Treatment of Hepatitis B virus (HBV) Infection Reduce Hepatitis Delta virus (HDV) Replication in HIV-HBV-HDV-Coinfected Patients? , 2008, Antiviral therapy.

[35]  Yi‐Hsiang Huang,et al.  Hepatitis B Surface Antigen Levels and Sequences of Natural Hepatitis B Virus Variants Influence the Assembly and Secretion of Hepatitis D Virus , 2007, Journal of Virology.

[36]  G. Dore,et al.  Highly endemic hepatitis B infection in rural Vietnam , 2007, Journal of gastroenterology and hepatology.

[37]  C. Yurdaydın,et al.  A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis , 2007, Journal of viral hepatitis.

[38]  A. Mele,et al.  Hepatitis delta in Europe: Vanishing or refreshing? , 2007, Hepatology.

[39]  C. Sureau,et al.  Entry of Hepatitis Delta Virus Requires the Conserved Cysteine Residues of the Hepatitis B Virus Envelope Protein Antigenic Loop and Is Blocked by Inhibitors of Thiol-Disulfide Exchange , 2007, Journal of Virology.

[40]  C. Sureau,et al.  Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity. , 2007, Virology.

[41]  M. Manns,et al.  Hepatitis D virus infection—Not a vanishing disease in Europe! , 2007, Hepatology.

[42]  M. Manns,et al.  [27] DIFFERENTIAL CYTOKINE PATTERN OF HDV-SPECIFIC CELLULAR IMMUNE RESPONSES DISTINGUISHES TREATMENT RESPONDER AND NONRESPONDER TO PEG-IFNa-2a TREATMENT: RESULTS FROM THE HEP-NET/INTERNATIONAL HIDIT-1 STUDY , 2007 .

[43]  M. Manns,et al.  HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration. , 2007, Journal of hepatology.

[44]  I. Yu,et al.  Large Hepatitis Delta Antigen Is a Novel Clathrin Adaptor-Like Protein , 2007, Journal of Virology.

[45]  Andrej Lupták,et al.  A Genomewide Search for Ribozymes Reveals an HDV-Like Sequence in the Human CPEB3 Gene , 2006, Science.

[46]  C. Trépo,et al.  HDV genotypes in the Western Brazilian Amazon region: A preliminary report. , 2006, The American journal of tropical medicine and hygiene.

[47]  A. Andriulli,et al.  Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta , 2006, Hepatology.

[48]  D. Häussinger,et al.  Treatment of chronic hepatitis delta with pegylated interferon‐α2b , 2006 .

[49]  P. Marcellin,et al.  Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up , 2006, Hepatology.

[50]  J. Trinchet,et al.  Eighth Major Clade for Hepatitis Delta Virus , 2006, Emerging infectious diseases.

[51]  C. Yurdaydın,et al.  Cytotoxic CD4+ T cells in viral hepatitis , 2006, Journal of viral hepatitis.

[52]  M. Lai,et al.  RNA-Templated Replication of Hepatitis Delta Virus: Genomic and Antigenomic RNAs Associate with Different Nuclear Bodies , 2006, Journal of Virology.

[53]  Shou-Dong Lee,et al.  Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. , 2006, Gastroenterology.

[54]  T. Nishizawa,et al.  Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia , 2006, Journal of medical virology.

[55]  J. Koskinas,et al.  Quantitative Analysis of Hepatitis D Virus RNA and Hepatitis B Surface Antigen Serum Levels in Chronic Delta Hepatitis Improves Treatment Monitoring , 2006, Antiviral therapy.

[56]  M. Schnölzer,et al.  Characterization of a hepatitis B and hepatitis delta virus receptor binding site , 2006, Hepatology.

[57]  N. Sut,et al.  Efficacy of interferon α‐2b and lamivudine combination treatment in comparison to interferon α‐2b alone in chronic delta hepatitis: A randomized trial , 2006 .

[58]  P. Pontisso,et al.  Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus–coinfected patients , 2006, Hepatology.

[59]  T. Nishizawa,et al.  High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia , 2005, Journal of medical virology.

[60]  B. Das,et al.  Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. , 2005, The Indian journal of medical research.

[61]  M. Manns,et al.  Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study , 2005, Alimentary pharmacology & therapeutics.

[62]  U. Akarca,et al.  Two-Year Interferon Therapy with Or without Ribavirin in Chronic Delta Hepatitis , 2005, Antiviral therapy.

[63]  R. Lanford,et al.  Mapping of the Hepatitis B Virus Pre-S1 Domain Involved in Receptor Recognition , 2005, Journal of Virology.

[64]  M. Lai.  RNA Replication without RNA-Dependent RNA Polymerase: Surprises from Hepatitis Delta Virus , 2005, Journal of Virology.

[65]  S. Urban,et al.  Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. , 2005, Gastroenterology.

[66]  H. Netter,et al.  Failure of the Lamivudine-Resistant rtM204I Hepatitis B Virus Mutants To Efficiently Support Hepatitis Delta Virus Secretion , 2005, Journal of Virology.

[67]  C. Alloui,et al.  Quantification of Hepatitis Delta Virus RNA in Serum by Consensus Real-Time PCR Indicates Different Patterns of Virological Response to Interferon Therapy in Chronically Infected Patients , 2005, Journal of Clinical Microbiology.

[68]  K. Demır,et al.  Alpha Interferon and Ribavirin Combination Therapy of Chronic Hepatitis D , 2005, Antimicrobial Agents and Chemotherapy.

[69]  S. Urban,et al.  Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2005 .

[70]  M. Lai,et al.  Hepatitis Delta Virus Antigen Is Methylated at Arginine Residues, and Methylation Regulates Subcellular Localization and RNA Replication , 2004, Journal of Virology.

[71]  Yi‐Hsiang Huang,et al.  Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus. , 2004, The Journal of general virology.

[72]  M. Milinkovitch,et al.  Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a Deltavirus Genus of at Least Seven Major Clades , 2004, Journal of Virology.

[73]  N. Enomoto,et al.  Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. , 2003, The Journal of general virology.

[74]  Ping Liu,et al.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. , 2003, The Journal of clinical investigation.

[75]  M. Manns,et al.  Analysis and function of delta-hepatitis virus-specific cellular immune responses , 2003 .

[76]  J. Casey,et al.  Inhibition of Hepatitis Delta Virus RNA Editing by Short Inhibitory RNA-Mediated Knockdown of ADAR1 but Not ADAR2 Expression , 2002, Journal of Virology.

[77]  M. Manns,et al.  Famciclovir treatment of chronic delta hepatitis. , 2002, Journal of hepatology.

[78]  Jinhong Chang,et al.  Parameters of Human Hepatitis Delta Virus Genome Replication: the Quantity, Quality, and Intracellular Distribution of Viral Proteins and RNA , 2002, Journal of Virology.

[79]  S. Hsu,et al.  Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications , 2002, Hepatology.

[80]  S. Semenov,et al.  Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. , 2001, The Journal of general virology.

[81]  S. Hadler,et al.  Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. , 2001, The Journal of general virology.

[82]  M. Garrubba,et al.  Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. , 2001, Liver.

[83]  K. Yano,et al.  Stimulation of RNA Polymerase II Elongation by Hepatitis Delta Antigen , 2001, Science.

[84]  C. Bréchot,et al.  Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein , 2001, Journal of Virology.

[85]  R. D. de Man,et al.  Lamivudine–high dose interferon combination therapy for chronic hepatitis B patients co‐infected with the hepatitis D virus , 2000 .

[86]  S. Hsu,et al.  Immunohistochemical differentiation of hepatitis D virus genotypes , 2000, Hepatology.

[87]  E. Sagnelli,et al.  Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis , 2000, Hepatology.

[88]  E. Sagnelli,et al.  Chronic hepatitis D: A vanishing disease? An Italian multicenter study , 2000, Hepatology.

[89]  A. Kidd,et al.  Recent High Incidence of Fulminant Hepatitis in Samara, Russia: Molecular Analysis of Prevailing Hepatitis B and D Virus Strains , 2000, Journal of Clinical Microbiology.

[90]  K. Russell,et al.  An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. , 2000, The American journal of tropical medicine and hygiene.

[91]  E. Christensen,et al.  Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B , 2000, Gut.

[92]  Charlotte.,et al.  Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections , 2000, Journal of viral hepatitis.

[93]  J. Hoofnagle,et al.  Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. , 1999, Gastroenterology.

[94]  J. Hoofnagle,et al.  Lamivudine for chronic delta hepatitis , 1999, Hepatology.

[95]  H. Hotta,et al.  Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan , 1999, Journal of medical virology.

[96]  O. Ciccarelli,et al.  Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis. , 1999, Journal of hepatology.

[97]  R. Purcell,et al.  Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope , 1998, Hepatology.

[98]  T. Chiang,et al.  Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. , 1998, The Journal of general virology.

[99]  F. Chang,et al.  Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factors , 1997, Journal of gastroenterology and hepatology.

[100]  J. Hoofnagle,et al.  Geographic distribution and genetic variability of hepatitis delta virus genotype I. , 1997, Virology.

[101]  A. Andriulli,et al.  The predominance of hepatitis delta virus genotype I among chronically infected Italian patients , 1997, Hepatology.

[102]  M. Houghton,et al.  Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles , 1997, Journal of virology.

[103]  K. Hyams,et al.  Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. , 1996, The Journal of infectious diseases.

[104]  F. Callea,et al.  Long‐term interferon‐α treatment of children with chronic hepatitis delta: a multicentre study , 1996 .

[105]  Wen-Hsiung Li,et al.  Substitution rates in hepatitis delta virus , 1995, Journal of Molecular Evolution.

[106]  K. Choo,et al.  Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome , 1995, Hepatology.

[107]  L. Rodrigo,et al.  Epidemiology of hepatitis D virus infection: changes in the last 14 years. , 1995, The American journal of gastroenterology.

[108]  K. Choo,et al.  Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D , 1995, The Lancet.

[109]  F. Kinjo,et al.  Seroepidemiological study of hepatitis delta virus infection in Okinawa, Japan , 1995, Journal of medical virology.

[110]  W. Sheng,et al.  Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. , 1995, Gastroenterology.

[111]  D. Mathieu,et al.  Long‐term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis , 1995, Hepatology.

[112]  F. Chisari,et al.  Expression of the hepatitis delta virus large and small antigens in transgenic mice , 1994, Journal of virology.

[113]  Shin C. Chang,et al.  Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus , 1994, Journal of virology.

[114]  J. Casey,et al.  A genotype of hepatitis D virus that occurs in northern South America. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[115]  J. Glenn,et al.  Identification of a prenylation site in delta virus large antigen. , 1992, Science.

[116]  J. Witte,et al.  Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. , 1992, JAMA.

[117]  G. Alexander,et al.  Hepatitis B and delta virus infection among "at risk" populations in south east London. , 1992, Journal of epidemiology and community health.

[118]  M. Lai,et al.  Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex , 1992, Journal of virology.

[119]  P. Chen,et al.  Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles , 1991, Journal of virology.

[120]  F. Imazeki,et al.  Heterogeneity and evolution rates of delta virus RNA sequences , 1990, Journal of virology.

[121]  M. Rizzetto,et al.  Hepatitis delta virus as a global health problem. , 1990, Vaccine.

[122]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[123]  M. Lai,et al.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[124]  B. J. Benenfeld,et al.  An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. , 1989, Science.

[125]  M. Houghton,et al.  A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta , 1988, Journal of virology.

[126]  G. Fattovich,et al.  Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. , 1987, The Journal of infectious diseases.

[127]  M. Rizzetto,et al.  A histological study of hepatitis delta virus liver disease , 1986, Hepatology.

[128]  H. Schellekens,et al.  The hepatitis delta (δ) virus possesses a circular RNA , 1986, Nature.

[129]  Michael Houghton,et al.  Structure, sequence and expression of the hepatitis delta (δ) viral genome , 1986, Nature.

[130]  S. Govindarajan,et al.  Fulminant B viral hepatitis: role of delta agent. , 1984, Gastroenterology.

[131]  S. Hadler,et al.  Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. , 1984, Annals of internal medicine.

[132]  N. Caporaso,et al.  Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. , 1983, Gastroenterology.

[133]  M. Colombo,et al.  Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. , 1983, Gastroenterology.

[134]  G. Kanel,et al.  Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. , 1983, Gastroenterology.

[135]  M. Rizzetto,et al.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. , 1983, Annals of internal medicine.

[136]  M. Rizzetto,et al.  Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. , 1983, American journal of epidemiology.

[137]  R. Purcell,et al.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[138]  M. Rizzetto,et al.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. , 1977, Gut.

[139]  P. Calès,et al.  Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[140]  J. Taylor,et al.  Structure and replication of hepatitis delta virus RNA. , 2006, Current topics in microbiology and immunology.

[141]  J. -. Wu,et al.  Functional and clinical significance of hepatitis D virus genotype II infection. , 2006, Current topics in microbiology and immunology.

[142]  P. Dény.  Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? , 2006, Current topics in microbiology and immunology.

[143]  C. Sureau.  The role of the HBV envelope proteins in the HDV replication cycle. , 2006, Current topics in microbiology and immunology.

[144]  R. Purcell,et al.  Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. , 2004, Gastroenterology.

[145]  P. Farci.  Delta hepatitis: an update. , 2003, Journal of hepatology.

[146]  E. Sagnelli,et al.  Decrease in HDV endemicity in Italy. , 1997, Journal of hepatology.

[147]  S. Hadziyannis.  Use of α-interferon in the treatment of chronic delta hepatitis , 1991 .

[148]  R. Purcell,et al.  Titration of the infectivity of hepatitis D virus in chimpanzees. , 1987, The Journal of infectious diseases.

[149]  M. Brunetto,et al.  Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. , 1987, Journal of hepatology.

[150]  G. Actis,et al.  Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy. , 1987, Digestion.

[151]  C. Trépo,et al.  Studies on the role of HDV in an outbreak of fulminant hepatitis in Bangui (Central African Republic). , 1987, Progress in clinical and biological research.

[152]  R. Moreira,et al.  High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. , 2005, The American journal of tropical medicine and hygiene.